A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India
Condition(s):Plaque Psoriasis; Psoriatic ArthritisLast Updated:March 1, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Plaque Psoriasis; Psoriatic ArthritisLast Updated:March 1, 2024Active, not recruiting
Condition(s):HIV/AIDSLast Updated:June 8, 2015Completed
Condition(s):Non-Small Cell Lung Cancer (NSCLC); Non-Small-Cell Lung Carcinoma; Nonsmall Cell Lung Cancer; Kidney Cancer; Kidney Neoplasms; Renal Cancer; Renal NeoplasmsLast Updated:December 4, 2020Completed
Condition(s):Obstetric Labor Complications; Post-partum Hemorrhage; Sepsis; Pre-eclampsia; Neonatal MortalityLast Updated:December 16, 2015Completed
Condition(s):Group A Beta Hemolytic Streptococcal (GAS) InfectionLast Updated:December 16, 2019Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 25, 2024Completed
Condition(s):Chronic DiseasesLast Updated:April 5, 2018Completed
Condition(s):Underweight; MalnutritionLast Updated:February 13, 2017Completed
Condition(s):HIV Infections; Heroin DependenceLast Updated:April 15, 2015Withdrawn
Condition(s):Major Depressive DisorderLast Updated:March 18, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.